You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Comparative efficacy and safety of oral P2Y12 inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis

Article metrics

Article menu
Meta-analysis
Original research
Comparative efficacy and safety of oral P2Y12 inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis

 

Online download statistics by month:

Online download statistics by month: April 2022 to August 2024

AbstractFullPdf
Apr 2022528575176
May 202226828791
Jun 202212513769
Jul 202210510248
Aug 202210110647
Sep 202210510669
Oct 2022899055
Nov 2022908554
Dec 202213112638
Jan 2023827918
Feb 20239710247
Mar 2023565632
Apr 2023464532
May 2023292714
Jun 2023272819
Jul 2023524827
Aug 2023454220
Sep 2023444015
Oct 2023414211
Nov 2023403922
Dec 202323123017
Jan 20241009913
Feb 2024515125
Mar 2024524922
Apr 2024464617
May 2024353412
Jun 2024545326
Jul 2024484227
Aug 2024282713
Total274627931076